CVRx (United States)

Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial

Uta C. Hoppe, Mathias C. Brandt, Rolf Wachter et al. · Journal of the American Society of Hypertension · 2012 · 284 citations

Hypertension, Heart Failure, Invasive System +10

Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction

William T. Abraham, Michael R. Zile, Fred A. Weaver et al. · JACC Heart Failure · 2015 · 276 citations · Full text

Baroreflex Activation Therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial

George L. Bakris, Mitra K. Nadim, Hermann Haller et al. · Journal of the American Society of Hypertension · 2012 · 241 citations

Non-pharmacological Intervention, Hypertension, Heart Failure +11

Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction

Michael R. Zile, JoAnn Lindenfeld, Fred A. Weaver et al. · Journal of the American College of Cardiology · 2020 · 192 citations · Full text

Chronic Baroreflex Activation Effects on Sympathetic Nerve Traffic, Baroreflex Function, and Cardiac Haemodynamics in Heart Failure: A Proof-of-Concept Study

Edoardo Gronda, Gino Seravalle, Gianmaria Brambilla et al. · European Journal of Heart Failure · 2014 · 179 citations · Full text